106 related articles for article (PubMed ID: 25532409)
1. [Building safety evidence body of shuxuetong injection].
Jiang JJ; Liao X; Xie YM
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3630-2. PubMed ID: 25532409
[TBL] [Abstract][Full Text] [Related]
2. [Systematic analysis on clinical safety of Shuxuetong injection].
Guo XF; Wen ZH; Xie YM; Liu SN; Li ZY; Chen DC
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2782-5. PubMed ID: 23285933
[TBL] [Abstract][Full Text] [Related]
3. [Spontaneous reportintg system data based on shuxuetong injection adverse reactions signal warning analysis].
Jiang JJ; Xiang YY; Xie YM; Shen H
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2994-7. PubMed ID: 24471318
[TBL] [Abstract][Full Text] [Related]
4. [32 546 intensive hospital monitoring cases of Shuxuetong injection].
Jiang JJ; Xie YM; Zhang Y; Yang ZX; Yi DH
Zhongguo Zhong Yao Za Zhi; 2016 Oct; 41(20):3852-3858. PubMed ID: 28929666
[TBL] [Abstract][Full Text] [Related]
5. [Study of post marketing safety reevaluation of shenqi fuzheng injection].
Ai QH; Li YY; Xie YM
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3633-6. PubMed ID: 25532410
[TBL] [Abstract][Full Text] [Related]
6. [Study of analysis 1 390 adverse drug reactions cases of parenterally administered dengzhan xixin based on China's spontaneous response system].
Li YY; Xiang YY; Xie YM; Shen H
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2998-3002. PubMed ID: 24471319
[TBL] [Abstract][Full Text] [Related]
7. [Impact analysis of parenterally administered shuxuetong on abnormal changes of BUN index based on hospital information system data].
Zhi YJ; Yang W; Xie YM; Zhang H; Yang H; Zhuang Y
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3048-52. PubMed ID: 24471328
[TBL] [Abstract][Full Text] [Related]
8. [Shuxuetong injection-based on nested case-control study of blood through injection suspect allergic reaction influencing factors].
Jiang JJ; Liao X; Xie YM; Zhang H; Yang H; Zhuang Y
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3555-8. PubMed ID: 25532394
[TBL] [Abstract][Full Text] [Related]
9. [Clinical outcomes of parenterally administered shuxuetong--analysis of hospital information system data].
Zhi YJ; Zhang H; Xie YM; Yang W; Yang H; Zhuang Y
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3116-20. PubMed ID: 24471338
[TBL] [Abstract][Full Text] [Related]
10. [Real-world study of effect on liver function of parenterally administered shuxuetong with different doses].
Wang ZF; Huo J; Jiang JJ; Xie YM
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3068-75. PubMed ID: 24471331
[TBL] [Abstract][Full Text] [Related]
11. [Impact analysis of shuxuetong injection on abnormal changes of ALT based on generalized boosted models propensity score weighting].
Yang W; Yi DH; Xie YM; Yang W; Dai Y; Zhi YJ; Zhuang Y; Yang H
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3039-47. PubMed ID: 24471327
[TBL] [Abstract][Full Text] [Related]
12. [Reasonable and safe application of Shuxuetong injection and intravenous medication's combined application in acute cerebral infarction's therapy].
Li MQ; Xie YM; Zhao JJ
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2742-3. PubMed ID: 23285924
[TBL] [Abstract][Full Text] [Related]
13. Establishment of safety evidence for Xingxue Shuxuening injection.
Yang W; Zhang W; Xie Y; Han B
J Tradit Chin Med; 2014 Oct; 34(5):604-8. PubMed ID: 25417413
[TBL] [Abstract][Full Text] [Related]
14. [Apply association rules to analysis adverse drug reactions of shuxuening injection based on spontaneous reporting system data].
Yang W; Xie YM; Xiang YY
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3616-20. PubMed ID: 25532406
[TBL] [Abstract][Full Text] [Related]
15. [Systematic report on re-evaluating kudiezi injection].
Liao X; Hua GQ; Xie YM; Liu DH
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3626-9. PubMed ID: 25532408
[TBL] [Abstract][Full Text] [Related]
16. [Systematic review of Shuxuetong injection for progressive ischaemic stroke].
Zhang YL; Liao X; Lv ZG; Hu J; Nie XL
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2774-8. PubMed ID: 23285931
[TBL] [Abstract][Full Text] [Related]
17. [Research on early warning signals of adverse drug reactions to parenterally administered xiyanping based on spontaneous reporting system (SRS) data].
Wang ZF; Xiang YY; Xie YM
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3008-12. PubMed ID: 24471321
[TBL] [Abstract][Full Text] [Related]
18. [Based on propensity score methods analysis of outcomes of parenterally administered shuxuetong in treatment of cerebral infarction].
Jiang JJ; Li L; Xie YM; Yang H; Zhuang Y
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3180-5. PubMed ID: 24471348
[TBL] [Abstract][Full Text] [Related]
19. [Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections].
Wang HN; Chen W; Fu Z; Du WM; He J
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):612-4. PubMed ID: 18536393
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening].
Yang W; Xiang YY; Xie YM; Shen H
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
